The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
International Consensus Study of Antipsychotic Dosing
Abstract
OBJECTIVE: Potency equivalents for anti-psychotic drugs are required to guide clinical dosing and for designing and interpreting research studies. Available dosing guidelines are limited by the methods and data from which they were generated. METHOD: With a two-step Delphi method, the authors surveyed a diverse group of international clinical and research experts, seeking consensus regarding antipsychotic dosing. The authors determined median clinical dosing equivalents and recommended starting, target range, and maximum doses for 61 drugs, adjusted for selected clinical circumstances. RESULTS: Participants (N=43) from 18 countries provided dosing recommendations regarding treatment of psychotic disorders for 37 oral agents and 14 short-acting and 10 long-acting parenteral agents. With olanzapine 20 mg/day as reference, estimated clinical equivalency ratios of oral agents ranged from 0.025 for sulpiride to 10.0 for trifluperidol. Seventeen patient and treatment characteristics, including age, hepatic and renal function, illness stage and severity, sex, and diagnosis, were associated with dosing modifications. CONCLUSIONS: In the absence of adequate prospective, randomized drug-drug comparisons, the present findings provide broad, international, expert consensus-based recommendations for most clinically employed antipsychotic drugs. They can support clinical practice, trial design, and interpretation of comparative antipsychotic trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Research guidelines for the Delphi survey technique
Hasson, F. (2000) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.2000.01567.x · Cited by 5,951
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics
Woods, S. W. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0607 · Cited by 2,050
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61764-x · Cited by 1,930
Jones, P. B., Barnes, T. R. E., Davies, L., Dunn, G., Lloyd, H., Hayhurst, K. P., Murray, R. M., Markwick, A., & Lewis, S. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1079 · Cited by 1,105
Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of Psychoses
Baldessarini, R. J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800250095013 · Cited by 545
Self-citationLeucht, S., Komossa, K., Rummel-Kluge, C., Corves, C., Hunger, H., Schmid, F., Asenjo Lobos, C., Schwarz, S., & Davis, J. M. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08030368 · Cited by 490
Leucht, S., Arbter, D., Engel, R. R., Kissling, W., & Davis, J. M. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002136 · Cited by 489
Heres, S., Davis, J., Maino, K., Jetzinger, E., Kissling, W., & Leucht, S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.185 · Cited by 450
Modern antipsychotic drugs: a critical overview
Gardner, D. M. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041064 · Cited by 422
Self-citation
Cited by
Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Örey, D., Richter, F., Samara, M., Barbui, C., Engel, R. R., Geddes, J. R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60733-3 · Cited by 2,561
Huhn, M., Nikolakopoulou, A., Schneider-Thoma, J., Krause, M., Samara, M., Peter, N., Arndt, T., Bäckers, L., Rothe, P., Cipriani, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31135-3 · Cited by 1,753
Howes, O. D., McCutcheon, R., Agid, O., de Bartolomeis, A., van Beveren, N. J. M., Birnbaum, M. L., Bloomfield, M. A. P., Bressan, R. A., Buchanan, R. W., Carpenter, W. T., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16050503 · Cited by 1,132
Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Salanti, G., & Davis, J. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60239-6 · Cited by 931
Using the Delphi expert consensus method in mental health research
Jorm, A. F. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415600891 · Cited by 765
Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1.
Leucht, S., Samara, M., Heres, S., & Davis, J. M. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv167 · Cited by 762
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Leucht, S., Leucht, C., Huhn, M., Chaimani, A., Mavridis, D., Helfer, B., Samara, M., Rabaioli, M., Bächer, S., Cipriani, A., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16121358 · Cited by 542
Hayasaka, Y., Purgato, M., Magni, L. R., Ogawa, Y., Takeshima, N., Cipriani, A., Barbui, C., Leucht, S., & Furukawa, T. A. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.021 · Cited by 401
“This is the of fi cial standard of reference for WHO member states. v) Expert consensus methods (Buckley, 2005; Gardner et al., 2010; Kane et al., 2003; Simpson et al., 2006).”
Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.025 · Cited by 385
Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method
Leucht, S., Samara, M., Heres, S., Patel, M. X., Woods, S. W., & Davis, J. M. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu001 · Cited by 372
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Self-citationBarnes, T. R., & the Schizophrenia Consensus Group of the British Association for Psychopharmacology (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110391123 · Cited by 356
Barch, D. M., Treadway, M. T., & Schoen, N. (2014) · Journal of Abnormal Psychology · doi:10.1037/a0036299 · Cited by 323
Dose Equivalents for Second-Generation Antipsychotic Drugs: The Classical Mean Dose Method
Leucht, S., Samara, M., Heres, S., Patel, M. X., Furukawa, T., Cipriani, A., Geddes, J., & Davis, J. M. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv037 · Cited by 318
Dose-response meta-analysis of antipsychotic drugs for acute schizophrenia
Leucht, S., Crippa, A., Siafis, S., Patel, M. X., Orsini, N., & Davis, J. M. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19010034 · Cited by 301
Samara, M. T., Dold, M., Gianatsi, M., Nikolakopoulou, A., Helfer, B., Salanti, G., & Leucht, S. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2955 · Cited by 300
Maintenance treatment with antipsychotic drugs for schizophrenia
Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., & Davis, J. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008016.pub2 · Cited by 290
Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
Demjaha, A., Lappin, J. M., Stahl, D., Patel, M. X., MacCabe, J. H., Howes, O. D., Heslin, M., Reininghaus, U. A., Donoghue, K., Lomas, B., et al. (2017) · Psychological Medicine · doi:10.1017/s0033291717000435 · Cited by 289
Mapping thalamocortical functional connectivity in chronic and early stages of psychotic disorders
Woodward, N. D., & Heckers, S. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.026 · Cited by 264
The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses
Haddad, P. M., & Correll, C. U. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125318781475 · Cited by 259
Dold, M., Aigner, M., Lanzenberger, R., & Kasper, S. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000740 · Cited by 211
Vancampfort, D., Probst, M., Scheewe, T., De Herdt, A., Sweers, K., Knapen, J., van Winkel, R., & De Hert, M. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2012.09.026 · Cited by 173
Çetin, M. S., Christensen, F., Abbott, C. C., Stephen, J. M., Mayer, A. R., Cañive, J. M., Bustillo, J. R., Pearlson, G. D., & Calhoun, V. D. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.04.009 · Cited by 154
Associations between sedentary behaviour and metabolic parameters in patients with schizophrenia
Vancampfort, D., Probst, M., Knapen, J., Carraro, A., & De Hert, M. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.03.046 · Cited by 149
Dold, M., Aigner, M., Lanzenberger, R., & Kasper, S. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv047 · Cited by 134
“In unrestricted maximum-likelihood meta-regression analyses, we investigated the impact of the continuous moderators: (1) mean administered antipsychotic dose (calculated as olanzapine equivalents according to the International Consensus Study of Antipsychotic Dosing [Gardner et al., 2010]); and (2) baseline symptom s…”
MethodInfluentialYildiz, A., Nikodem, M., Vieta, E., Correll, C. U., & Baldessarini, R. J. (2015) · Psychological Medicine · doi:10.1017/s0033291714001305 · Cited by 128
Self-citationEstimating Dopamine D2 Receptor Occupancy for Doses of 8 Antipsychotics: A Meta-Analysis
Lako, I. M., van den Heuvel, E. R., Knegtering, H., Bruggeman, R., & Taxis, K. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182983ffa · Cited by 125
Reduced model-based decision-making in schizophrenia.
Culbreth, A. J., Westbrook, A., Daw, N. D., Botvinick, M., & Barch, D. M. (2016) · Journal of Abnormal Psychology · doi:10.1037/abn0000164 · Cited by 104
Leucht, S., Priller, J., & Davis, J. M. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20240738 · Cited by 117
Cuesta, M. J., Sánchez-Torres, A. M., Cabrera, B., Bioque, M., Merchán-Naranjo, J., Corripio, I., González-Pinto, A., Lobo, A., Bombín, I., de la Serna, E., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.02.022 · Cited by 111
Woodward, N. D., & Heckers, S. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv048 · Cited by 85
Leucht, S., Schneider‐Thoma, J., Burschinski, A., Peter, N., Wang, D., Dong, S., Huhn, M., Nikolakopoulou, A., Salanti, G., & Davis, J. M. (2023) · World Psychiatry · doi:10.1002/wps.21089 · Cited by 78
Dong, S., Schneider-Thoma, J., Bighelli, I., Siafis, S., Wang, D., Burschinski, A., Schestag, K., Samara, M., & Leucht, S. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01654-2 · Cited by 68
Dold, M., Kautzky, A., Bartova, L., Rabl, U., Souery, D., Mendlewicz, J., Porcelli, S., Serretti, A., Zohar, J., Montgomery, S., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.10.005 · Cited by 66
“…with previous surveys and the recommendations of the treatment guidelines, we found that the dispensed mean doses of the antipsychotics were considerably lower than those commonly used in the pharmacological management of schizophrenic disorders (Dold and Leucht, 2014; Gardner et al., 2010).”
Functional Connectivity of the Striatum in Schizophrenia and Psychotic Bipolar Disorder
Karcher, N. R., Rogers, B. P., & Woodward, N. D. (2019) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2019.05.017 · Cited by 65
Life satisfaction and happiness among young adults with schizophrenia
Fervaha, G., Agid, O., Takeuchi, H., Foussias, G., & Remington, G. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.05.046 · Cited by 61
Gjerden, P., Bramness, J. G., Tvete, I. F., & Slørdal, L. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2281-8 · Cited by 48
Predicting Remission in Subjects at Clinical High Risk for Psychosis Using Mismatch Negativity
Kim, M., Lee, T. H., Yoon, Y. B., Lee, T. Y., & Kwon, J. S. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx102 · Cited by 45
Reward-driven decision-making impairments in schizophrenia
Saperia, S., Da Silva, S., Siddiqui, I., Agid, O., Daskalakis, Z. J., Ravindran, A., Voineskos, A. N., Zakzanis, K. K., Remington, G., & Foussias, G. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2018.11.004 · Cited by 41
Metabolic and inflammatory genes in schizophrenia
Chase, K. A., Rosen, C., Gin, H., Bjorkquist, O., Feiner, B., Marvin, R., Conrin, S., & Sharma, R. P. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2014.11.007 · Cited by 41
Emsley, R., Asmal, L., Rubio, J. M., Correll, C. U., & Kane, J. M. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.025 · Cited by 41
Antipsychotic Dose in Acute Schizophrenia: A Meta-analysis
Takeuchi, H., MacKenzie, N. E., Samaroo, D., Agid, O., Remington, G., & Leucht, S. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa063 · Cited by 39
Huhn, M., Leucht, C., Rothe, P., Dold, M., Heres, S., Bornschein, S., Schneider-Axmann, T., Hasan, A., & Leucht, S. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01109-y · Cited by 38
Thomas, N., Shawyer, F., Castle, D. J., Copolov, D., Hayes, S. C., & Farhall, J. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-198 · Cited by 35
“Antipsychotic medication Antipsychotic medication changes and dosages are tracked at each assessment point and will be converted to chlorpromazine-equivalent dosages [73].”
BackgroundDiabetes, physical activity participation and exercise capacity in patients with schizophrenia
Vancampfort, D., De Hert, M., Sweers, K., De Herdt, A., Detraux, J., & Probst, M. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12077 · Cited by 34
Tanda, G., Valentini, V., De Luca, M. A., Perra, V., Serra, G. P., & Di Chiara, G. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3780-2 · Cited by 33
Bogers, J. P. A. M., Hambarian, G., Michiels, M., Vermeulen, J., & de Haan, L. (2020) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgaa002 · Cited by 33
Koch, M. T., Carlson, H. E., Kazimi, M. M., & Correll, C. U. (2023) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2023.03.007 · Cited by 31
Wang, D., Schneider-Thoma, J., Siafis, S., Burschinski, A., Dong, S., Wu, H., Zhu, Y., Davis, J. M., Priller, J., & Leucht, S. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad089 · Cited by 29
Olsen, E. K., Bjorkquist, O. A., Bodapati, A. S., Shankman, S. A., & Herbener, E. S. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.09.012 · Cited by 27
“Chlorpromazine equivalent dosages were derived from Gardner et al. (2010) (see Table 2).”
BackgroundMoon, S.-Y., Choi, Y. B., Jung, H. K., Lee, Y. I., & Choi, S.-H. (2018) · Psychiatry Investigation · doi:10.30773/pi.2018.09.30 · Cited by 19
Vázquez-Bourgon, J., Ortiz-García de la Foz, V., Gómez-Revuelta, M., Mayoral-van Son, J., Juncal-Ruiz, M., Garrido-Torres, N., & Crespo-Facorro, B. (2022) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac033 · Cited by 18
Enhanced Automatic Action Imitation and Intact Imitation-Inhibition in Schizophrenia
Simonsen, A., Fusaroli, R., Skewes, J. C., Roepstorff, A., Campbell-Meiklejohn, D., Mors, O., & Bliksted, V. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby006 · Cited by 16
Chan, S. K. W., Chan, K. K. S., Hui, C. L., Wong, G. H. Y., Chang, W. C., Lee, E. H. M., Tang, J. Y. M., & Chen, E. Y. H. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2013.11.028 · Cited by 12
She, S., Deng, Y., Chen, Y., Wu, C., Yi, W., Lu, X., Chen, X., Li, J., Li, R., Zhang, J., et al. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.04.054 · Cited by 9
Kishi, T., Matsuda, Y., Sakuma, K., Okuya, M., & Iwata, N. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.08.003 · Cited by 8
A neural mechanism underlying predictive visual motion processing in patients with schizophrenia
Scheliga, S., Schwank, R., Scholle, R., Habel, U., & Kellermann, T. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114934 · Cited by 8
Liang, Y., Su, Y.-A., Zhao, Z.-G., Gao, N., Huang, J.-Z., Tang, M.-Q., Li, K.-Q., Yang, F.-D., Yu, X., & Si, T.-M. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000379 · Cited by 6
“To obtain comparable doses for each group, we converted each medication to chlorpromazine equivalents.(17) As shown in Table 1, there was no significant difference in stable doses among”
Methodde Filippis, R., Aloi, M., Liuzza, M. T., Pugliese, V., Carbone, E. A., Rania, M., Segura-Garcia, C., & De Fazio, P. (2024) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2024.152496 · Cited by 6
Zhang, T., Su, M., Huo, X., & Zhao, X. (2025) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2025.100628 · Cited by 3
Rodak, J., Witusik, A., Nowakowska-Domagała, K., Pietras, T., & Mokros, Ł. (2018) · Postępy Psychiatrii i Neurologii · doi:10.5114/ppn.2018.77034 · Cited by 2
Metadata
- Authors
- Gardner, D. M., Murphy, A. L., O'Donnell, H., Centorrino, F., & Baldessarini, R. J.
- Venue
- American Journal of Psychiatry
- Published
- 2010-06-01
- Volume
- 167
- Issue
- 6
- Pages
- 686-693
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2165988750
- Cited by
- 1,301
- References
- 30
- FWCI
- 26.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.